A Solid Dispersion of Quercetin Shows Enhanced Nrf2 Activation and Protective Effects Against Oxidative Injury in a Mouse Model of Dry Age-Related Macular Degeneration

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2019 Nov 30

PMID 31781321

Citations 30

Authors

Yan Shao

Haitao Yu

Yan Yang

Min Li

Li Hang

Xinrong Xu

Affiliations

Soon will be listed here.

Abstract

Age-related macular degeneration (AMD) represents a major reason for blindness in the elderly population. Oxidative stress is a predominant factor in the pathology of AMD. We previously evaluated the effects of phospholipid complex of quercetin (Q-PC) on oxidative injury in ARPE-19 cells, but the underlying mechanisms are not fully understood. Herein, the solid dispersion of quercetin-PC (Q-SD) was prepared with solubility being 235.54 g/mL in water and 2.3×10 g/mL in chloroform, which were significantly higher than that of quercetin (QT) and Q-PC. Q-SD also exhibited a considerably higher dissolution rate than QT and Q-PC. Additionally, Q-SD had Cmax of 4.143 g/mL and AUC of 12.015 g·h/mL in rats, suggesting better bioavailability than QT and Q-PC. Then, a mouse model of dry AMD (Nrf2 wild-type (WT) and Nrf2 knockout (KO)) was established for evaluating the effects of Q-SD in vivo. Q-SD more potently reduced retinal pigment epithelium sediments and Bruch's membrane thickness than QT and Q-PC at 200 mg/kg in Nrf2 WT mice and did not work in Nrf2 KO mice at the same dosage. Additionally, Q-SD significantly decreased ROS and MDA contents and restored SOD, GSH-PX, and CAT activities of serum and retinal tissues in Nrf2 WT mice, but not in Nrf2 KO mice. Furthermore, Q-SD more potently increased Nrf2 mRNA expression and stimulated its nuclear translocation in retinal tissues of Nrf2 WT mice. Q-SD significantly increased the expression of Nrf2 target genes HO-1, HQO-1, and GCL of retinal tissues in Nrf2 WT mice, not in Nrf2 KO mice. Altogether, Q-SD had improved physicochemical and pharmacokinetic properties compared to QT and Q-PC and exhibited more potent protective effects on retina oxidative injury in vivo. These effects were associated with activation of Nrf2 signaling and upregulation of antioxidant enzymes.

Citing Articles

Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment Strategies.

Azam M, Jastrzebska B Cells. 2025; 14(1.

PMID: 39791750 PMC: 11720364. DOI: 10.3390/cells14010049.

Perspectives of traditional herbal medicines in treating retinitis pigmentosa.

Liu S, Matsuo T, Matsuo C, Abe T, Chen J, Sun C Front Med (Lausanne). 2024; 11:1468230.

PMID: 39712182 PMC: 11660805. DOI: 10.3389/fmed.2024.1468230.

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.

Rojo A, Buttari B, Cadenas S, Carlos A, Cuadrado A, Falcao A Redox Biol. 2024; 79():103464.

PMID: 39709790 PMC: 11733061. DOI: 10.1016/j.redox.2024.103464.

Beneficial Effects of -Derived Bioactive Compounds in the Epigenetic Program of Neurodevelopment.

Russo C, Valle M, DAngeli F, Surdo S, Giunta S, Barbera A Nutrients. 2024; 16(14).

PMID: 39064669 PMC: 11280255. DOI: 10.3390/nu16142225.

New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation.

Zhang L, Xu L, Tang F, Liu D, Zhao X, Zhang J J Pharm Anal. 2024; 14(6):100930.

PMID: 39005843 PMC: 11245930. DOI: 10.1016/j.jpha.2023.12.020.

References

Hanneken A, Lin F, Johnson J, Maher P . Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci. 2006; 47(7):3164-77. DOI: 10.1167/iovs.04-1369. View

. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001; 119(10):1439-52. PMC: 1472812. DOI: 10.1001/archopht.119.10.1439. View

Zhao Z, Chen Y, Wang J, Sternberg P, Freeman M, Grossniklaus H . Age-related retinopathy in NRF2-deficient mice. PLoS One. 2011; 6(4):e19456. PMC: 3084871. DOI: 10.1371/journal.pone.0019456. View

Xu X, Li M, Chen W, Yu H, Yang Y, Hang L . Apigenin Attenuates Oxidative Injury in ARPE-19 Cells thorough Activation of Nrf2 Pathway. Oxid Med Cell Longev. 2016; 2016:4378461. PMC: 5021875. DOI: 10.1155/2016/4378461. View

Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo G . The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol. 2011; 83(1):6-15. DOI: 10.1016/j.bcp.2011.08.010. View

Huang Y, Dai W . Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B. 2015; 4(1):18-25. PMC: 4590721. DOI: 10.1016/j.apsb.2013.11.001. View

Yang L, Shao Y, Han H . Development of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailability. Eur J Pharm Sci. 2015; 78:103-10. DOI: 10.1016/j.ejps.2015.07.007. View

Sies H, Berndt C, Jones D . Oxidative Stress. Annu Rev Biochem. 2017; 86:715-748. DOI: 10.1146/annurev-biochem-061516-045037. View

Maiti K, Mukherjee K, Gantait A, Saha B, Mukherjee P . Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol. 2006; 58(9):1227-33. DOI: 10.1211/jpp.58.9.0009. View

10.

Singh D, Rawat M, Semalty A, Semalty M . Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. Curr Drug Discov Technol. 2011; 9(1):17-24. DOI: 10.2174/157016312799304507. View

11.

Pershing S, Talwar N, Armenti S, Grubbs Jr J, Rosenthal J, Dedania V . Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept. Am J Ophthalmol. 2019; 207:385-394. PMC: 6856411. DOI: 10.1016/j.ajo.2019.05.011. View

12.

Wang H, Cui Y, Fu Q, Deng B, Li G, Yang J . A phospholipid complex to improve the oral bioavailability of flavonoids. Drug Dev Ind Pharm. 2014; 41(10):1693-703. DOI: 10.3109/03639045.2014.991402. View

13.

Khan A, Kotta S, Ansari S, Sharma R, Ali J . Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier. Drug Dev Ind Pharm. 2014; 41(5):772-9. DOI: 10.3109/03639045.2014.902466. View

14.

Shinde V, Shelake M, Shetty S, Chavan-Patil A, Pore Y, Late S . Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. J Pharm Pharmacol. 2008; 60(9):1121-9. DOI: 10.1211/jpp.60.9.0002. View

15.

Gillies M, Hunyor A, Arnold J, Guymer R, Wolf S, Ng P . Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA Ophthalmol. 2019; 137(4):372-379. PMC: 6459213. DOI: 10.1001/jamaophthalmol.2018.6776. View

16.

Ma Q . Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53:401-26. PMC: 4680839. DOI: 10.1146/annurev-pharmtox-011112-140320. View

17.

Chiras D, Kitsos G, Petersen M, Skalidakis I, Kroupis C . Oxidative stress in dry age-related macular degeneration and exfoliation syndrome. Crit Rev Clin Lab Sci. 2014; 52(1):12-27. DOI: 10.3109/10408363.2014.968703. View

18.

Singh S, Vrishni S, Singh B, Rahman I, Kakkar P . Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res. 2010; 44(11):1267-88. DOI: 10.3109/10715762.2010.507670. View

19.

Cai X, Fang Z, Dou J, Yu A, Zhai G . Bioavailability of quercetin: problems and promises. Curr Med Chem. 2013; 20(20):2572-82. DOI: 10.2174/09298673113209990120. View

20.

Xu X, Yu H, Yang Y, Hang L, Yang X, Ding S . Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway. Eur J Pharmacol. 2015; 770:1-8. DOI: 10.1016/j.ejphar.2015.11.050. View